Meeting
2015 Gastrointestinal Cancers Symposium
Effect of TP53 mutation status on survival in the MAGIC trial.
Authors
Elizabeth Catherine Smyth
Royal Marsden NHS Foundation Trust, London and Surrey, United Kingdom
Elizabeth Catherine Smyth , Sanna Hulkki Wilson , Matthew Guy Nankivell , David Gonzalez de Castro , Andrew Wotherspoon , Alicia Frances Clare Okines , Ruth E Langley , Sally Patricia Stenning , David Cunningham
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A: Cancers of the Esophagus and Stomach
Track
Cancers of the Esophagus and Stomach
Sub Track
Translational Research
Citation
J Clin Oncol 33, 2015 (suppl 3; abstr 71)
DOI
10.1200/jco.2015.33.3_suppl.71
Abstract #
71
Poster Bd #
B21
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
ELLA01-1: A study to determine the utility of TP53 mutations as a prognostic biomarker in adenoid cystic carcinoma.
First Author: Robert Metcalf
Poster
2015 Gastrointestinal Cancers Symposium
Prognostic and predictive effect of microsatellite instability (MSI) in MAGIC.
First Author: Elizabeth Catherine Smyth
First Author: Elizabeth Catherine Smyth
Poster
2011 ASCO Annual Meeting
Evaluation of p53 mutation as a predictive biomarker for outcome to chemotherapy in ovarian cancer.
First Author: A. H. Calvert